Global Opioid Rescue Products Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	200 Pages	TechNavio	November, 2024	INF19463290

Best Price Guarantee
Price	from $2,500
Length	200 Pages
Publisher	TechNavio
Published Date	November, 2024
SKU	INF19463290

Opioid Rescue Products Market 2024-2028

The opioid rescue products market is forecasted to grow by USD 1689.8 mn during 2023-2028, accelerating at a CAGR of 11.6% during the forecast period. The report on the opioid rescue products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing rates of opioid overdoses, government initiatives to address opioid crisis, and enhanced awareness and educational efforts.

Technavio's opioid rescue products market is segmented as below:

By Distribution Channel

Offline
Online

By Product Type

Naloxone
Naltrexone
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the approval of new drugs as one of the prime reasons driving the opioid rescue products market growth during the next few years. Also, formation of partnerships and agreements and emphasis on over-the-counter availability will lead to sizable demand in the market.

The report on the opioid rescue products market covers the following areas:

Opioid Rescue Products Market sizing
Opioid Rescue Products Market forecast
Opioid Rescue Products Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading opioid rescue products market vendors that include Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Catalent Inc., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals Plc, Kyowa Kirin Co. Ltd., Mallinckrodt Plc, Novartis AG, Orexo AB, Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the opioid rescue products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Product Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value Chain Analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2023; 4.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size: 5.1 Global Opioid Rescue Products Market 2018 - 2022; Historic Market Size - Data Table on Global Opioid Rescue Products Market 2018 - 2022 ($ million); 5.2 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 5.3 Product Type segment analysis 2018 - 2022; Historic Market Size - Product Type Segment 2018 - 2022 ($ million); 5.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 5.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on the Global Opioid Rescue Products Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 7.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Distribution Channel: 8.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 8.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 8.3 Offline - Market size and forecast 2023-2028; Chart on Offline - Market size and forecast 2023-2028 ($ million); Data Table on Offline - Market size and forecast 2023-2028 ($ million); Chart on Offline - Year-over-year growth 2023-2028 (%); Data Table on Offline - Year-over-year growth 2023-2028 (%); 8.4 Online - Market size and forecast 2023-2028; Chart on Online - Market size and forecast 2023-2028 ($ million); Data Table on Online - Market size and forecast 2023-2028 ($ million); Chart on Online - Year-over-year growth 2023-2028 (%); Data Table on Online - Year-over-year growth 2023-2028 (%); 8.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Product Type: 9.1 Market segments; Chart on Product Type - Market share 2023-2028 (%); Data Table on Product Type - Market share 2023-2028 (%); 9.2 Comparison by Product Type; Chart on Comparison by Product Type; Data Table on Comparison by Product Type; 9.3 Naloxone - Market size and forecast 2023-2028; Chart on Naloxone - Market size and forecast 2023-2028 ($ million); Data Table on Naloxone - Market size and forecast 2023-2028 ($ million); Chart on Naloxone - Year-over-year growth 2023-2028 (%); Data Table on Naloxone - Year-over-year growth 2023-2028 (%); 9.4 Naltrexone - Market size and forecast 2023-2028; Chart on Naltrexone - Market size and forecast 2023-2028 ($ million); Data Table on Naltrexone - Market size and forecast 2023-2028 ($ million); Chart on Naltrexone - Year-over-year growth 2023-2028 (%); Data Table on Naltrexone - Year-over-year growth 2023-2028 (%); 9.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 9.6 Market opportunity by Product Type; Market opportunity by Product Type ($ million); Data Table on Market opportunity by Product Type ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 11.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 11.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 11.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 11.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 11.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 11.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 11.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 11.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 11.12 Spain - Market size and forecast 2023-2028; Chart on Spain - Market size and forecast 2023-2028 ($ million); Data Table on Spain - Market size and forecast 2023-2028 ($ million); Chart on Spain - Year-over-year growth 2023-2028 (%); Data Table on Spain - Year-over-year growth 2023-2028 (%); 11.13 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 11.14 South Korea - Market size and forecast 2023-2028; Chart on South Korea - Market size and forecast 2023-2028 ($ million); Data Table on South Korea - Market size and forecast 2023-2028 ($ million); Chart on South Korea - Year-over-year growth 2023-2028 (%); Data Table on South Korea - Year-over-year growth 2023-2028 (%); 11.15 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 11.16 Brazil - Market size and forecast 2023-2028; Chart on Brazil - Market size and forecast 2023-2028 ($ million); Data Table on Brazil - Market size and forecast 2023-2028 ($ million); Chart on Brazil - Year-over-year growth 2023-2028 (%); Data Table on Brazil - Year-over-year growth 2023-2028 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Alkermes Public Ltd. Co.; Alkermes Public Ltd. Co. - Overview; Alkermes Public Ltd. Co. - Product / Service; Alkermes Public Ltd. Co. - Key offerings; SWOT; 14.5 Amneal Pharmaceuticals Inc.; Amneal Pharmaceuticals Inc. - Overview; Amneal Pharmaceuticals Inc. - Business segments; Amneal Pharmaceuticals Inc. - Key news; Amneal Pharmaceuticals Inc. - Key offerings; Amneal Pharmaceuticals Inc. - Segment focus; SWOT; 14.6 Emergent BioSolutions Inc.; Emergent BioSolutions Inc. - Overview; Emergent BioSolutions Inc. - Product / Service; Emergent BioSolutions Inc. - Key offerings; SWOT; 14.7 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 14.8 Fresenius Kabi AG; Fresenius Kabi AG - Overview; Fresenius Kabi AG - Product / Service; Fresenius Kabi AG - Key offerings; SWOT; 14.9 Hikma Pharmaceuticals Plc; Hikma Pharmaceuticals Plc - Overview; Hikma Pharmaceuticals Plc - Business segments; Hikma Pharmaceuticals Plc - Key news; Hikma Pharmaceuticals Plc - Key offerings; Hikma Pharmaceuticals Plc - Segment focus; SWOT; 14.10 Kyowa Kirin Co. Ltd.; Kyowa Kirin Co. Ltd. - Overview; Kyowa Kirin Co. Ltd. - Product / Service; Kyowa Kirin Co. Ltd. - Key offerings; SWOT; 14.11 Mallinckrodt Plc; Mallinckrodt Plc - Overview; Mallinckrodt Plc - Business segments; Mallinckrodt Plc - Key news; Mallinckrodt Plc - Key offerings; Mallinckrodt Plc - Segment focus; SWOT; 14.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 14.13 Orexo AB; Orexo AB - Overview; Orexo AB - Product / Service; Orexo AB - Key offerings; SWOT; 14.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.15 Purdue Pharma LP; Purdue Pharma LP - Overview; Purdue Pharma LP - Product / Service; Purdue Pharma LP - Key offerings; SWOT; 14.16 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 14.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT; 14.18 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2023 and 2028; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value Chain Analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits24: Historic Market Size - Data Table on Global Opioid Rescue Products Market 2018 - 2022 ($ million); Exhibits25: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits26: Historic Market Size - Product Type Segment 2018 - 2022 ($ million); Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits29: Five forces analysis - Comparison between 2023 and 2028; Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits35: Chart on Market condition - Five forces 2023 and 2028; Exhibits36: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits37: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits38: Chart on Comparison by Distribution Channel; Exhibits39: Data Table on Comparison by Distribution Channel; Exhibits40: Chart on Offline - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Offline - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Offline - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Online - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Online - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Distribution Channel ($ million); Exhibits49: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits50: Chart on Product Type - Market share 2023-2028 (%); Exhibits51: Data Table on Product Type - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Product Type; Exhibits53: Data Table on Comparison by Product Type; Exhibits54: Chart on Naloxone - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Naloxone - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Naloxone - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Naloxone - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Naltrexone - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Naltrexone - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Naltrexone - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Naltrexone - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Product Type ($ million); Exhibits67: Data Table on Market opportunity by Product Type ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Spain - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on Spain - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on Spain - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Spain - Year-over-year growth 2023-2028 (%); Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits117: Chart on South Korea - Market size and forecast 2023-2028 ($ million); Exhibits118: Data Table on South Korea - Market size and forecast 2023-2028 ($ million); Exhibits119: Chart on South Korea - Year-over-year growth 2023-2028 (%); Exhibits120: Data Table on South Korea - Year-over-year growth 2023-2028 (%); Exhibits121: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits122: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits123: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits124: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits125: Chart on Brazil - Market size and forecast 2023-2028 ($ million); Exhibits126: Data Table on Brazil - Market size and forecast 2023-2028 ($ million); Exhibits127: Chart on Brazil - Year-over-year growth 2023-2028 (%); Exhibits128: Data Table on Brazil - Year-over-year growth 2023-2028 (%); Exhibits129: Market opportunity By Geographical Landscape ($ million); Exhibits130: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits131: Impact of drivers and challenges in 2023 and 2028; Exhibits132: Overview on criticality of inputs and factors of differentiation; Exhibits133: Overview on factors of disruption; Exhibits134: Impact of key risks on business; Exhibits135: Companies covered; Exhibits136: Company ranking index; Exhibits137: Matrix on companies position and classification; Exhibits138: Alkermes Public Ltd. Co. - Overview; Exhibits139: Alkermes Public Ltd. Co. - Product / Service; Exhibits140: Alkermes Public Ltd. Co. - Key offerings; Exhibits141: SWOT; Exhibits142: Amneal Pharmaceuticals Inc. - Overview; Exhibits143: Amneal Pharmaceuticals Inc. - Business segments; Exhibits144: Amneal Pharmaceuticals Inc. - Key news; Exhibits145: Amneal Pharmaceuticals Inc. - Key offerings; Exhibits146: Amneal Pharmaceuticals Inc. - Segment focus; Exhibits147: SWOT; Exhibits148: Emergent BioSolutions Inc. - Overview; Exhibits149: Emergent BioSolutions Inc. - Product / Service; Exhibits150: Emergent BioSolutions Inc. - Key offerings; Exhibits151: SWOT; Exhibits152: F. Hoffmann La Roche Ltd. - Overview; Exhibits153: F. Hoffmann La Roche Ltd. - Business segments; Exhibits154: F. Hoffmann La Roche Ltd. - Key news; Exhibits155: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits156: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits157: SWOT; Exhibits158: Fresenius Kabi AG - Overview; Exhibits159: Fresenius Kabi AG - Product / Service; Exhibits160: Fresenius Kabi AG - Key offerings; Exhibits161: SWOT; Exhibits162: Hikma Pharmaceuticals Plc - Overview; Exhibits163: Hikma Pharmaceuticals Plc - Business segments; Exhibits164: Hikma Pharmaceuticals Plc - Key news; Exhibits165: Hikma Pharmaceuticals Plc - Key offerings; Exhibits166: Hikma Pharmaceuticals Plc - Segment focus; Exhibits167: SWOT; Exhibits168: Kyowa Kirin Co. Ltd. - Overview; Exhibits169: Kyowa Kirin Co. Ltd. - Product / Service; Exhibits170: Kyowa Kirin Co. Ltd. - Key offerings; Exhibits171: SWOT; Exhibits172: Mallinckrodt Plc - Overview; Exhibits173: Mallinckrodt Plc - Business segments; Exhibits174: Mallinckrodt Plc - Key news; Exhibits175: Mallinckrodt Plc - Key offerings; Exhibits176: Mallinckrodt Plc - Segment focus; Exhibits177: SWOT; Exhibits178: Novartis AG - Overview; Exhibits179: Novartis AG - Business segments; Exhibits180: Novartis AG - Key news; Exhibits181: Novartis AG - Key offerings; Exhibits182: Novartis AG - Segment focus; Exhibits183: SWOT; Exhibits184: Orexo AB - Overview; Exhibits185: Orexo AB - Product / Service; Exhibits186: Orexo AB - Key offerings; Exhibits187: SWOT; Exhibits188: Pfizer Inc. - Overview; Exhibits189: Pfizer Inc. - Product / Service; Exhibits190: Pfizer Inc. - Key news; Exhibits191: Pfizer Inc. - Key offerings; Exhibits192: SWOT; Exhibits193: Purdue Pharma LP - Overview; Exhibits194: Purdue Pharma LP - Product / Service; Exhibits195: Purdue Pharma LP - Key offerings; Exhibits196: SWOT; Exhibits197: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits198: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits199: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits200: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits201: SWOT; Exhibits202: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits203: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits204: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits205: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits206: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits207: SWOT; Exhibits208: Viatris Inc. - Overview; Exhibits209: Viatris Inc. - Business segments; Exhibits210: Viatris Inc. - Key news; Exhibits211: Viatris Inc. - Key offerings; Exhibits212: Viatris Inc. - Segment focus; Exhibits213: SWOT; Exhibits214: Inclusions checklist; Exhibits215: Exclusions checklist; Exhibits216: Currency conversion rates for US$; Exhibits217: Research methodology; Exhibits218: Information sources; Exhibits219: Data validation; Exhibits220: Validation techniques employed for market sizing; Exhibits221: Data synthesis; Exhibits222: 360 degree market analysis; Exhibits223: List of abbreviations